Incidence of malignancy in Japanese patients with rheumatoid arthritis

Rheumatology International

Volumn 31, Issue 11, 2011, Pages 1487-1492

  Yamada, Toru ^a   Nakajima, Ayako ^a   Inoue, Eisuke ^a   Tanaka, Eiichi ^a   Taniguchi, Atsuo ^a   Momohara, Shigeki ^a   Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cancer; Comorbidity; Incidence; Lung cancer; Lymphoma; Malignancy; Rheumatoid arthritis; Risk factor

Indexed keywords

ADULT; AGE; ARTICLE; BLADDER CANCER; CANCER INCIDENCE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; JAPANESE; KIDNEY CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEOPLASM; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; STOMACH CANCER;

ARTHRITIS, RHEUMATOID; COMORBIDITY; FEMALE; HEALTH STATUS; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 80052715653     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1524-0     Document Type: Article

References (36)

1. C Turesson WM O'Fallon CS Crowson SE Gabriel EL Matteson 2002 Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis J Rheumatol 29 62 67 11824973 (Pubitemid 34041860)
2. A Young G Koduri M Batley, et al. 2007 Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis Rheumatology (Oxford) 46 350 357 10.1093/rheumatology/kel253 1:STN:280:DC%2BD2s%2FktVGrtA%3D%3D (Pubitemid 46189799)
3. T Kuroda N Tanabe T Harada, et al. 2006 Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis Clin Rheumatol 25 498 505 16267602 10.1007/s10067-005-0079-z (Pubitemid 44137623)
4. H Maradit-Kremers PJ Nicola CS Crowson KV Ballman SE Gabriel 2005 Cardiovascular death in rheumatoid arthritis: a population-based study Arthritis Rheum 52 722 732 15751097 10.1002/art.20878 (Pubitemid 40365093)
5. S Wallberg-Jonsson ML Ohman SR Dahlqvist 1997 Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden J Rheumatol 24 445 451 9058647 1:STN:280:DyaK2s3htFKrsg%3D%3D (Pubitemid 27153406)
6. Y Hoshida JX Xu S Fujita, et al. 2007 Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication J Rheumatol 34 322 331 17117491 1:CAS:528: DC%2BD2sXjtFCnsbc%3D
7. AL Smitten HK Choi MC Hochberg, et al. 2008 The risk of hospitalized infection in patients with rheumatoid arthritis J Rheumatol 35 387 393 18260176 (Pubitemid 351374409)
8. AL Smitten TA Simon MC Hochberg S Suissa 2008 A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis Arthritis Res Ther 10 R45 18433475 10.1186/ar2404 (Pubitemid 351722568)
9. L Abasolo E Judez MA Descalzo I Gonzalez-Alvaro JA Jover L Carmona 2008 Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a south European population Semin Arthritis Rheum 37 388 397 17977580 10.1016/j.semarthrit.2007.08.006 (Pubitemid 351734521)
10. J Llorca MJ Lopez-Diaz C Gonzalez-Juanatey WE Ollier J Martin MA Gonzalez-Gay 2007 Persistent chronic inflammation contributes to the development of cancer in patients with rheumatoid arthritis from a defined population of northwestern Spain Semin Arthritis Rheum 37 31 38 17360028 10.1016/j.semarthrit. 2007.01.002 (Pubitemid 47087888)
11. J Franklin M Lunt D Bunn D Symmons A Silman 2007 Influence of inflammatory polyarthritis on cancer incidence and survival: results from a community-based prospective study Arthritis Rheum 56 790 798 17328051 10.1002/art.22430 (Pubitemid 46399426)
12. P Geborek A Bladstrom C Turesson, et al. 2005 Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas Ann Rheum Dis 64 699 703 15695534 10.1136/ard.2004.030528 1:CAS:528:DC%2BD2MXksFWrurc%3D (Pubitemid 40559295)
13. P Prior DP Symmons CF Hawkins DL Scott R Brown 1984 Cancer morbidity in rheumatoid arthritis Ann Rheum Dis 43 128 131 6712287 10.1136/ard.43.2.128 1:STN:280:DyaL2c7nslGmug%3D%3D (Pubitemid 14125170)
14. J Cibere J Sibley M Haga 1997 Rheumatoid arthritis and the risk of malignancy Arthritis Rheum 40 1580 1586 9324011 10.1002/art.1780400906 1:STN:280:DyaK2svmsVWqsg%3D%3D (Pubitemid 27426150)
15. P Beauparlant K Papp B Haraoui 1999 The incidence of cancer associated with the treatment of rheumatoid arthritis Semin Arthritis Rheum 29 148 158 10622679 10.1016/S0049-0172(99)80026-2 1:STN:280:DC%2BD3c%2Fos1eqsw%3D%3D (Pubitemid 30013279)
16. J Askling CM Fored E Baecklund, et al. 2005 Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists Ann Rheum Dis 64 1414 1420 15843454 10.1136/ard.2004.033241 1:STN:280:DC%2BD2MvptFCitg%3D%3D (Pubitemid 41623850)
17. S Setoguchi DH Solomon ME Weinblatt, et al. 2006 Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis Arthritis Rheum 54 2757 2764 16947774 10.1002/art.22056 1:CAS:528:DC%2BD28XhtFWksLjO (Pubitemid 44497754)
18. L Mellemkjaer MS Linet G Gridley M Frisch H Moller JH Olsen 1996 Rheumatoid arthritis and cancer risk Eur J Cancer 32A 1753 1757 8983286 10.1016/0959-8049(96)00210-9 1:STN:280:DyaK2s7gsFKntQ%3D%3D (Pubitemid 26306889)
19. E Thomas DH Brewster RJ Black GJ Macfarlane 2000 Risk of malignancy among patients with rheumatic conditions Int J Cancer 88 497 502 11054684 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J 1:STN:280:DC%2BD3crgsl2guw%3D%3D
20. L Georgescu GC Quinn S Schwartzman SA Paget 1997 Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment Semin Arthritis Rheum 26 794 804 9213378 10.1016/S0049-0172(97)80023-6 1:STN:280:DyaK2szls12ntA%3D%3D (Pubitemid 27274443)
21. E Baecklund A Iliadou J Askling, et al. 2006 Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis Arthritis Rheum 54 692 701 16508929 10.1002/art.21675
22. M Kojima H Itoh K Hirabayashi, et al. 2006 Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases Pathol Res Pract 202 679 685 16859835 10.1016/j.prp.2006.05.007
23. F Shinomiya N Mima K Nanba, et al. 2008 Life expectancies of Japanese patients with rheumatoid arthritis: a review of deaths over a 20-year period Mod Rheumatol 18 165 169 18317879 10.1007/s10165-008-0031-6
24. Nakajima A, Inoue E, Tanaka E, Singh G, Sato E, Hoshi D, Shidara K, Hara M, Momohara S, Taniguchi A, Kamatani N, Yamanaka H (2010) Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol (in press)
25. H Yamanaka E Inoue G Singh, et al. 2007 Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan Mod Rheumatol 17 283 289 17694260 10.1007/s10165-007-0587-6 (Pubitemid 47263818)
26. T Yamada A Nakajima E Inoue, et al. 2006 Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan Ann Rheum Dis 65 1661 1663 16837491 10.1136/ard.2005.047274 1:STN:280:DC%2BD28jgvFKjtQ%3D%3D (Pubitemid 44799684)
27. A Nakajima S Kamitsuji A Saito, et al. 2006 Disability and patient's appraisal of general health contribute to depressed mood in rheumatoid arthritis in a large clinical study in Japan Mod Rheumatol 16 151 157 16767553 10.1007/s10165-006-0475-5 (Pubitemid 43871690)
28. Y Matsuda G Singh H Yamanaka, et al. 2003 Validation of a Japanese version of the Stanford health assessment questionnaire in 3, 763 patients with rheumatoid arthritis Arthritis Rheum 49 784 788 14673964 10.1002/art.11465 (Pubitemid 37523630)
29. T Matsuda T Marugame K Kamo K Katanoda W Ajiki T Sobue 2008 Cancer incidence and incidence rates in Japan in 2002: Based on data from 11 population-based cancer registries Jpn J Clin Oncol 38 641 648 18708647 10.1093/jjco/hyn074
30. SF Kingsmore BD Hall NB Allen JR Rice DS Caldwell 1992 Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review J Rheumatol 19 1462 1465 1433017 1:STN:280: DyaK3s%2FlvFShsA%3D%3D
31. TR Bachman AD Sawitzke SL Perkins JH Ward GW Cannon 1996 Methotrexate-associated lymphoma in patients with rheumatoid arthritis: report of two cases Arthritis Rheum 39 325 329 8849387 10.1002/art.1780390223 1:STN:280:DyaK287pslShsg%3D%3D (Pubitemid 26065275)
32. Y Hoshida Y Tomita D Zhiming, et al. 2004 Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection Int J Cancer 108 443 449 14648712 10.1002/ijc.11582 1:CAS:528:DC%2BD3sXhtVSlsr7E (Pubitemid 37549611)
33. R Rizzi P Curci M Delia, et al. 2009 Spontaneous remission of "Methotrexate-associated lymphoproliferative disorders" After discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature Med Oncol 26 1 9 18461290 10.1007/s12032-008-9069-8 1:CAS:528:DC%2BD1MXjsVKqsLY%3D
34. T Miyazaki K Fujimaki Y Shirasugi, et al. 2007 Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection Am J Hematol 82 1106 1109 17654684 10.1002/ajh.21003 1:CAS:528:DC%2BD2sXhsVyhurjN (Pubitemid 350209856)
35. S Bernatsky A Clarke S Suissa 2008 Lung cancer after exposure to disease modifying anti-rheumatic drugs Lung Cancer 59 266 269 17673329 10.1016/j.lungcan.2007.06.013 (Pubitemid 351173401)
36. F Wolfe K Michaud 2007 The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19, 562 patients during 89, 710 person-years of observation Arthritis Rheum 56 1433 1439 17469100 10.1002/art.22579 1:CAS:528:DC%2BD2sXmsFart7o%3D (Pubitemid 46764070)